Nurse Practitioner in Conneaut Lake, PA Accepting Medicare
2 Nurse Practitioner nurses found. Showing 1 - 2
 Serena E Mott, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10926 State Highway 18, Conneaut Lake, PA 16316 Phone: 814-382-0446 Fax: 814-382-7386 |
Kaelyn R Betts, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 8507 State Higway 285, Conneaut Lake, PA 16316 Phone: 814-382-5703 Fax: 814-382-5707 |
News Archive
Most of the fatal falls in the home can be avoided with fall prevention and protection products
Healthcare costs are rapidly increasing due to the rapid aging of our population. The Center for Disease Control and Prevention indicates that over 60% of fatal falls occur in the home. Additionally, the total cost of falls in 2010 is expected to be between 68 and 100 Billion Dollars. More than 25,000 older adults died due to falls last year.
MorphoSys unveils next-generation antibody technology Ylanthia
MorphoSys AG today unveiled its next-generation antibody technology Ylanthia®. The technology was presented to an audience of specialists at the 2011 Antibody Engineering and Antibody Therapeutics Conference in San Diego. MorphoSys expects Ylanthia to set new standards for therapeutic antibody generation in the pharmaceutical industry over the next decade and beyond. Commercial application will commence in 2012.
HIV advocates in Uganda 'losing faith' as country works to prevent, treat new infections, PlusNews reports
PlusNews examines how "corruption scandals, frequent treatment shortages and accusations of a misguided prevention program" have undermined progress in the fight against HIV/AIDS in Uganda, a country that had "won plaudits in the early days of the epidemic for the aggressive stance taken by President Yoweri Museveni." Uganda "lowered its HIV prevalence from 18 percent in the early 1990s to about six percent in 2000," the news service notes.
Combination regimen improves overall survival in certain patients with AML
A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over azacitidine alone in certain patients with acute myeloid leukemia (AML), according to the Phase III VIALE-A trial led by The University of Texas MD Anderson Cancer Center.
› Verified 8 days ago